Home » ALNYLAM PHARMA AMENDS RNAI AGREEMENTS WITH MERCK
ALNYLAM PHARMA AMENDS RNAI AGREEMENTS WITH MERCK
July 10, 2006
Alnylam Pharmaceuticals, a biopharmaceutical company developing novel therapeutics based on RNA interference, has amended its two existing RNAi collaboration agreements with Merck and consolidated the efforts into a single ongoing collaboration.
KEYWORDS Daily International Pharma Alert